2.27
price down icon1.30%   -0.03
after-market Handel nachbörslich: 2.22 -0.05 -2.20%
loading
Schlusskurs vom Vortag:
$2.30
Offen:
$2.37
24-Stunden-Volumen:
14,100
Relative Volume:
0.34
Marktkapitalisierung:
$87.45M
Einnahmen:
$24.38M
Nettoeinkommen (Verlust:
$-53.95M
KGV:
-0.919
EPS:
-2.47
Netto-Cashflow:
$-23.31M
1W Leistung:
+6.07%
1M Leistung:
-22.26%
6M Leistung:
-30.58%
1J Leistung:
-22.26%
1-Tages-Spanne:
Value
$2.07
$2.37
1-Wochen-Bereich:
Value
$2.05
$2.37
52-Wochen-Spanne:
Value
$1.87
$5.24

Elutia Inc Stock (ELUT) Company Profile

Name
Firmenname
Elutia Inc
Name
Telefon
240-247-1143
Name
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Name
Mitarbeiter
51
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-14
Name
Neueste SEC-Einreichungen
Name
ELUT's Discussions on Twitter

Vergleichen Sie ELUT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
ELUT
Elutia Inc
2.27 87.45M 24.38M -53.95M -23.31M -2.47
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Elutia Inc Stock (ELUT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-11-02 Eingeleitet Cantor Fitzgerald Overweight
2020-11-02 Eingeleitet Cowen Outperform
2020-11-02 Eingeleitet Piper Sandler Overweight
2020-11-02 Eingeleitet Truist Buy

Elutia Inc Aktie (ELUT) Neueste Nachrichten

pulisher
04:22 AM

Elutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29 | ELUT Stock News - GuruFocus

04:22 AM
pulisher
04:05 AM

Elutia's Top Scientist Reveals Drug Development Strategy: Key Regulatory Catalysts in Focus - Stock Titan

04:05 AM
pulisher
04:04 AM

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29 - TradingView

04:04 AM
pulisher
Apr 21, 2025

Elutia (ELUT) Begins EluPro Clinical Study to Enhance Patient Outcomes | ELUT Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice | ELUT Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice - The Manila Times

Apr 21, 2025
pulisher
Apr 21, 2025

Elutia Inc. Initiates Clinical Study for EluPro™ to Enhance Cardiac Device Outcomes - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Elutia Begins Landmark Registry Study for Revolutionary CIED Protection Technology EluPro - Stock Titan

Apr 21, 2025
pulisher
Apr 15, 2025

Elutia (ELUT) Reports Resilience Amid Global Tariff Changes | EL - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

Elutia Confirms No Material Impact from Global Tariffs | ELUT St - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Elutia unaffected by global tariffs, maintains US focus By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Elutia unaffected by global tariffs, maintains US focus - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Elutia Unaffected by Global Tariffs Due to US-Based Operations - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Elutia Confirms No Material Impact from Global Tariffs - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

US-Made Medical Devices: How Elutia Dodges Global Tariff Pressures - Stock Titan

Apr 14, 2025
pulisher
Apr 11, 2025

Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common StockSEC Filing - MarketScreener

Apr 11, 2025
pulisher
Apr 04, 2025

Elutia Brokers GPO Agreement with Advantus Health Partners - Medical Product Outsourcing

Apr 04, 2025
pulisher
Apr 04, 2025

Eluta Slumps on Recognition - Baystreet.ca

Apr 04, 2025
pulisher
Apr 04, 2025

EluPro™ Named as 2025 Edison Award Winner - The Manila Times

Apr 04, 2025
pulisher
Apr 04, 2025

Revolutionary Medical Device EluPro Clinches Edison Award: Game-Changer for 600,000 Annual Heart Implants - Stock Titan

Apr 04, 2025
pulisher
Apr 03, 2025

Elutia to Participate in Upcoming Investor Conferences - TradingView

Apr 03, 2025
pulisher
Apr 03, 2025

Exclusive Investor Access: Elutia CEO to Showcase Drug-Eluting Innovation at Premier Conferences - Stock Titan

Apr 03, 2025
pulisher
Apr 03, 2025

AIGH Capital Management LLC Has $11.50 Million Position in Elutia Inc. (NASDAQ:ELUT) - MarketBeat

Apr 03, 2025
pulisher
Apr 02, 2025

Elutia to Debut EluPro™ at HRS 2025Experience the Difference Biology Makes - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

Revolutionary Biological CIED Protection: Elutia Unveils Dual-Antibiotic EluPro Technology - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

Elutia Inc. reports mixed preliminary 2024 financial results - MSN

Apr 01, 2025
pulisher
Mar 27, 2025

Elutia Inc. secures deal with Advantus Health Partners By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro?? - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Elutia Enters GPO Deal With Advantus Health Partners - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Elutia Inc. secures deal with Advantus Health Partners - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™ - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

Healthcare Milestone: Elutia Secures 7th GPO Deal for Revolutionary Antibiotic Device - Stock Titan

Mar 27, 2025
pulisher
Mar 25, 2025

Elutia publishes new preclinical data in Antibiotics - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Groundbreaking Clinical Data: Elutia's FDA-Cleared Device Eliminates All Tested Bacteria - Stock Titan

Mar 25, 2025
pulisher
Mar 18, 2025

Elutia Files For Mixed Shelf Of Up To $100 MillionSEC Filing -March 18, 2025 at 06:23 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Elutia stock soars, Anteris falls in medical devices sector By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 17, 2025

Elutia stock soars, Anteris falls in medical devices sector - Investing.com India

Mar 17, 2025
pulisher
Mar 14, 2025

HighCape Capital buys $1.05 million in Elutia Inc. stock - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

HighCape Capital buys $1.05 million in Elutia Inc. stock By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Elutia Inc. sees $1.05 million stock purchase by HighCape entities - Investing.com Australia

Mar 13, 2025
pulisher
Mar 11, 2025

Elutia Inc. Reports Strong Demand for EluPro™ - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

ELUTIA INC. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Elutia Inc. (ELUT) reports earnings - qz.com

Mar 11, 2025
pulisher
Mar 10, 2025

Earnings call transcript: Elutia Q4 2024 misses forecasts, stock drops By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Elutia’s (ELUT) “Overweight” Rating Reiterated at Cantor Fitzgerald - Defense World

Mar 10, 2025
pulisher
Mar 07, 2025

Earnings call transcript: Elutia Q4 2024 misses forecasts, stock drops - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out - The Manila Times

Mar 07, 2025
pulisher
Mar 07, 2025

Elutia Inc (ELUT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Product Growth ... - Yahoo Finance

Mar 07, 2025

Finanzdaten der Elutia Inc-Aktie (ELUT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Kapitalisierung:     |  Volumen (24h):